Condition: Deprescriptions · Antidepressive Agents · Antipsychotic Agents · Sponsor: Ludwig-Maximilians - University of Munich
The PARTNER study is a multicentre, two-arm, pragmatic cluster-randomised trial evaluating the impact of a focused and patient-centred cooperation between general practitioners (GPs) and community pharmacists (PARTNER intervention) on reductions in the use of psychotropic, sedative and anticholinergic potentially inappropriate medication (PSA-PIM) compared to a control intervention. The PARTNER intervention comprises (1) education for health care professionals, (2) an interprofessional workshop and case conference, (3) a pharmacy visit with brown bag/medication review and patient empowerment, (4) GP practice visit with shared decision making. The control intervention only comprises a pharmacy visit with brown bag review.
This description comes directly from the study's public registry record.
Tobias Dreischulte, Prof. Dr. · +49 89 4400 55447 · tobias.dreischulte@med.uni-muenchen.de
Annette Haerdtlein · +49 89 4400 54976 · annette.haerdtlein@med.uni-muenchen.de
Always discuss trial participation with your own doctor first.
| University of Bielefeld | Bielefeld, Germany | Not Yet Recruiting |
| University Hospital, LMU Munich | Munich, Germany | Recruiting |
| Witten/Herdecke University | Witten, Germany | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05842928